Original-Research: ELARIS AG (von GBC AG): GBC Management ...
GNW-Adhoc: US FDA approves Idorsia's once-daily TRYVIO (aprocitentan) ...
GNW-Adhoc: Idorsia and Viatris successfully close the transaction ...
EQS-News: Multitude SE: CapitalBox Launches SME-Focused ...
GNW-Adhoc: Idorsia presents at the J.P. Morgan Healthcare ...
Original-Research: Mexedia SPA-SB (von GBC AG): Buy